Physician and Patient Attitudes Toward Screening for Kidney Complications in Type 2 Diabetes: Is There A Role for Patient Self-Advocacy?
2018 ◽
Vol 2
(1)
◽
pp. 72-74
Keyword(s):
Urine protein screening rates among patients with type 2 diabetes are suboptimal despite evidence supporting its efficacy in preventing or slowing the progression of diabetic kidney disease (DKD) [1]. Testing of untimed urine specimens to quantify albumin (urine albumin-creatinine, or uACR)-the recommended screening test based on combination of simplicity, cost, and cardiovascular and renal prognostic value-is particularly underutilized, despite longitudinal efforts to improve awareness and screening among physicians [2].
2021 ◽
Vol 12
◽
pp. 215013272110036
Keyword(s):
2019 ◽
Vol 37
(7)
◽
pp. 1411-1418
◽
Keyword(s):
Keyword(s):